Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L

References

• Smyth M J, Godfrey D I, Trapani J A. A fresh look at tumor immunosurveillance and immunotherapy. Natural Immunology 2001; 2: 293–299
   PubMed Web of Science ®Google Scholar
• Whiteside T L, Miescher S, Hurlimann J, Moretta L, von Fliedner V. Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors. International Journal of Cancer 1986; 37: 803–811
   PubMed Web of Science ®Google Scholar
• Lotzova E. Role of human circulating and tumor-infiltrating lymphocytes in cancer defense and treatment. Natural Immunology & Cell Growth Regulation 1990; 9: 253–264
   PubMedGoogle Scholar
• Liu Y J, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Natural Immunology 2001; 2: 585–589
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Nagashima N, Onitsuka K, et al. Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. Anticancer Research 2003; 23: 4423–4426
   PubMed Web of Science ®Google Scholar
• Eisenthal A, Polyvkin N, Bramante-Schreiber L, Misonznik F, Hassner A, Lifschitz-Mercer B. Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Human Pathology 2001; 32: 803–807
   PubMed Web of Science ®Google Scholar
• Ishigami S, Aikou T, Natsugoe S, Hokita S, Iwashige H, Tokushige M, Sonoda S. Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 1998; 55: 65–69
   Web of Science ®Google Scholar
• Inoshima N, Nakanishi Y, Minami T, Izumi M, Takayama K, Yoshino I, Hara N. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clinical Cancer Research 2002; 8: 3480–3486
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, Mabuchi H, Nohara T, et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. International Journal of Cancer 2003; 104: 92–97
   PubMed Web of Science ®Google Scholar
• Reichert T E, Scheuer C, Day R, Wagner W, Whiteside T L. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 2001; 91: 2136–2147
   PubMed Web of Science ®Google Scholar
• Taki C, Kitajima S, Sueyoshi K, Yonezawa S, Tanaka S, Sakoda K, et al. MUC1 mucin expression in follicular dendritic cells and lymphoepithelial lesions of gastric mucosa-associated lymphoid tissue lymphoma. Pathology International 2002; 52: 691–701
   PubMed Web of Science ®Google Scholar
• Ratta M, Fagnoni F, Curti A, Vescovini R, Sansoni P, Oliviero B, et al. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood 2002; 100: 230–237
   PubMed Web of Science ®Google Scholar
• Mohty M, Isnardon D, Vey N, Briere F, Blaise D, Olive D, Gaugler B. Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34 + /CD38−primitive haematopoietic progenitors. British Journal of Haematology 2002; 119: 115–118
   PubMed Web of Science ®Google Scholar
• Mohty M, Jarrossay D, Lafage-Pochitaloff M, Zandotti C, Briere F, de Lamballeri X N, et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001; 98: 3750–3756
   PubMed Web of Science ®Google Scholar
• Waller E K, Rosenthal H, Jones T W, Peel J, Lonial S, Langston A, et al. Larger numbers of CD4 bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001; 97: 2948–2956
   PubMed Web of Science ®Google Scholar
• Tanis W, Mancham S, Binda R, Janssen H L, Bezemer G, Ijeermans J N, et al. Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells. Clinical Immunology 2004; 110: 81–88
   PubMed Web of Science ®Google Scholar
• Takahashi K, Asagoe K, Zaishun J, Yanai H, Yoshino T, Hayashi K, Akagi T. Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. American Journal of Pathology 1998; 153: 745–755
   PubMed Web of Science ®Google Scholar
• Soilleux E J, Morris L S, Leslie G, Chehimi J, Luo Q, Levroney E, et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. Journal of Leukocyte Biology 2002; 71: 445–457
   PubMed Web of Science ®Google Scholar
• Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B, et al. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Research 2003; 63: 6478–6487
   PubMed Web of Science ®Google Scholar
• Sparwasser T, Vabulas R M, Villmow B, Lipford G B, Wagner H. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. European Journal of Immunology 2000; 30: 3591–3597
   PubMed Web of Science ®Google Scholar
• Pribila J T, Itano A A, Mueller K L, Shimizu Y. The {alpha}1{beta}1 and {alpha}E{beta}7 integrins define a subset of dendritic cells in peripheral lymph nodes with unique adhesive and antigen uptake properties. Journal of Immunology 2004; 172: 282–291
   PubMed Web of Science ®Google Scholar
• Mazzoni A, Segal D M. Controlling the toll road to dendritic cell polarization. Journal of Leukocyte Biology 2004; 75: 721–730
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamaguchi H, Ishizeki J, Nakajima T, Nakazato Y. Immunohistochemical and immunoelectron microscopic localization of S-100 protein in the interdigitating reticulum cells of the human lymph node. Virchows Archives of B Cell Pathology Including Molecular Pathology 1981; 37: 125–135
   PubMedGoogle Scholar
• Inaba K, Pack M, Inaba M, Sakuta H, Isdell F, Steinman R M. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. Journal of Experimental Medicine 1997; 186: 665–672
   PubMed Web of Science ®Google Scholar
• MacDonald K P, Munster D J, Clark G J, Dzionek A, Schmitz J, Hart D N. Characterization of human blood dendritic cell subsets. Blood 2002; 100: 4512–4520
   PubMed Web of Science ®Google Scholar
• MacDonald K PA, Munster D J, Clark G J, Dzionek A, Schmitz J, Hart D NJ. Characterization of human blood dendritic cell subsets. Blood 2002; 100: 4512–4520
   PubMed Web of Science ®Google Scholar
• Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon {alpha}/{beta} induction. Journal of Experimental Medicine 2001; 194: 1823–1834
   PubMed Web of Science ®Google Scholar
• Kadowaki N, Ho S, Antonenko S, de Waal Malefyt R, Kastelein R A, Bazan F, Liu Y -J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. Journal of Experimental Medicine 2001; 194: 863–870
   PubMed Web of Science ®Google Scholar
• Siegal F P, Kadowaki N, Shodell M, Fitzgerald-Bocarsly P A, Shah K, Ho S, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835–1837
   PubMed Web of Science ®Google Scholar
• Kuwana M, Kaburaki J, Wright T M, Kawakami Y, Ikeda Y. Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. European Journal of Immunology 2001; 31: 2547–2557
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Journal of Clinical Oncology 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Dorfman D M, Schultze J L, Shahsafaei A, Michalak S, Gribben J G, Freeman G J, et al. In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation. Blood 1997; 90: 4297–4306
   PubMed Web of Science ®Google Scholar
• Petrasch S, Brittinger G, Wacker H H, Schmitz J, Kosco-Vilbois M. Follicular dendritic cells in non-Hodgkin's lymphomas. Leukemia & Lymphoma 1994; 15: 33–43
   PubMed Web of Science ®Google Scholar
• Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. Journal of Immunology 2000; 165: 6037–6046
   PubMed Web of Science ®Google Scholar
• Kellermann S -A, Hudak S, Oldham E R, Liu Y -J, McEvoy L M. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3{beta} are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. Journal of Immunology 1999; 162: 3859–3864
   PubMed Web of Science ®Google Scholar
• Gunn M D, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams L T, Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. Journal of Experimental Medicine 1999; 189: 451–460
   PubMed Web of Science ®Google Scholar
• Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23–33
   PubMed Web of Science ®Google Scholar
• Cambi A, de Lange F, van Maarseveen N M, Nijhuis M, Joosten B, van Dijk E MHP, et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. Journal of Cell Biology 2004; 164: 145–155
   PubMed Web of Science ®Google Scholar
• Figdor C G, van Kooyk Y, Adema G J. C-type lectin receptors on dendritic cells and Langerhans cells. Natural Reviews in Immunology 2002; 2: 77–84
   PubMed Web of Science ®Google Scholar
• Kanazawa N, Tashiro K, Inaba K, Miyachi Y. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor {gamma} chain. Journal of Biological Chemistry 2003; 278: 32645–32652
   PubMed Web of Science ®Google Scholar
• Ramakrishna V, Treml J F, Vitale L, Connolly J E, O'Neill T, Smith P A, et al. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. Journal of Immunology 2004; 172: 2845–2852
   PubMed Web of Science ®Google Scholar
• Irjala H, Alanen K, Grenman R, Heikkila P, Joensuu H, Jalkanen S. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Research 2003; 63: 4671–4676
   PubMed Web of Science ®Google Scholar
• Irjala H, Johansson E L, Grenman R, Alanen K, Salmi M, Jalkanen S. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. Journal of Experimental Medicine 2001; 194: 1033–1042
   PubMed Web of Science ®Google Scholar
• Chieppa M, Bianchi G, Doni A, Del Prete A, Sironi M, Laskarin G, et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. Journal of Immunology 2003; 171: 4552–4560
   PubMed Web of Science ®Google Scholar
• Friedl P, Gunzer M. Interaction of T cells with APCs: the serial encounter model. Trends in Immunology 2001; 22: 187–191
   PubMed Web of Science ®Google Scholar
• Gunzer M, Schafer A, Borgmann S, Grabbe S, Zanker K S, Brocker E B, et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 2000; 13: 323–332
   PubMed Web of Science ®Google Scholar
• van Kooyk Y, Geijtenbeek T B. DC-SIGN: escape mechanism for pathogens. Natural Reviews in Immunology 2003; 3: 697–709
   PubMed Web of Science ®Google Scholar
• Sansom D M, Manzotti C N, Zheng Y. What's the difference between CD80 and CD86?. Trends in Immunology 2003; 24: 314–319
   PubMed Web of Science ®Google Scholar